C.M. Bidwell & Associates »

Blueprint Medicines shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $77k 827 92.50

More positions owned by C.M. Bidwell & Associates

Vanguard Short-Term Bond ETF (BSV)
iShares Russell 2000 Index (IWM)
iShares Russell 1000 Index (IWB)
Vanguard Total Stock Market ETF (VTI)
Vanguard S&p 500 Etf idx (VOO)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Ishares Tr core strm usbd (ISTB)
Vanguard Intermediate-Term Bond ETF (BIV)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Europe Pacific ETF (VEA)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Total Bond Market ETF (BND)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr 0 (SCHP)
Vanguard Mun Bd Fd Inc tax-exempt bd (VTEB)

View all positions for C.M. Bidwell & Associates

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines